Trademark: 79293529
Word

Status
Registered
Status Code
700
Status Date
Tuesday, April 27, 2021
Serial Number
79293529
Registration Number
6331211
Registration Date
Tuesday, April 27, 2021
Mark Type
2000
Filing Date
Friday, July 10, 2020
Published for Opposition
Tuesday, February 9, 2021

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The mark consists of a starburst in the middle of and overlapping three polygons.

Trademark Events
Aug 29, 2021
Final Decision Transaction Processed By Ib
Aug 10, 2021
Final Disposition Notice Sent To Ib
Aug 10, 2021
Final Disposition Processed
Jul 27, 2021
Final Disposition Notice Created, To Be Sent To Ib
Apr 27, 2021
Registered-Principal Register
Feb 9, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 9, 2021
Published For Opposition
Jan 20, 2021
Notification Of Notice Of Publication E-Mailed
Jan 1, 2021
Approved For Pub - Principal Register
Dec 22, 2020
Teas/Email Correspondence Entered
Dec 21, 2020
Correspondence Received In Law Office
Dec 21, 2020
Teas Response To Office Action Received
Nov 22, 2020
Refusal Processed By Ib
Nov 2, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Nov 2, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 2, 2020
Teas Change Of Correspondence Received
Nov 2, 2020
Teas Change Of Domestic Representatives Address
Nov 2, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 2, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 2, 2020
Teas Change Of Owner Address Received
Nov 2, 2020
Refusal Processed By Mpu
Oct 10, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Oct 9, 2020
Non-Final Action Written
Oct 5, 2020
Assigned To Examiner
Sep 29, 2020
Application Filing Receipt Mailed
Sep 25, 2020
New Application Office Supplied Data Entered In Tram
Sep 21, 2020
Limitation From Original Application Entered
Sep 17, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24